$IVZ
Invesco Ltd Stock $ivz

$ivz Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000091420824000219 Filed on February 21, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.475B	$1.413B	$5.716B
YoY Change	4.03%	-2.08%	-5.5%
Cost Of Revenue	$504.0M	$459.4M	$1.825B
YoY Change	10.74%	2.71%	-3.23%
Gross Profit	$971.3M	$954.0M	$3.891B
YoY Change	0.85%	-4.23%	-6.52%
Gross Profit Margin	65.84%	67.5%	68.07%
Selling, General & Admin	$746.9M	$769.5M	$2.986B
YoY Change	641.71%	3.26%	8.17%
% of Gross Profit	76.9%	80.66%	76.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.30M	$60.30M	$98.80M
YoY Change	-75.85%	210.82%	54.86%
% of Gross Profit	1.16%	6.32%	2.54%
Operating Expenses	$758.2M	$829.8M	$3.084B
YoY Change	-37.27%	8.53%	9.23%
Operating Profit	$213.1M	$124.2M	$806.8M
YoY Change	1.72%	-46.35%	-39.74%
Interest Expense	$3.400M	$13.60M	$48.60M
YoY Change	-81.11%	-51.43%	7.28%
% of Operating Profit	1.6%	10.95%	6.02%
Other Income/Expense, Net	$66.40M	$128.7M	$148.3M
YoY Change	142.34%	9.72%	-228.62%
Pretax Income	$282.9M	-$933.5M	-$237.9M
YoY Change	20.03%	-339.11%	-119.07%
Income Tax	$68.70M	-$266.4M	-$69.70M
% Of Pretax Income	24.28%
Net Earnings	$141.5M	-$742.3M	-$333.7M
YoY Change	-2.41%	-495.26%	-148.79%
Net Earnings / Revenue	9.59%	-52.52%	-5.84%
Basic Earnings Per Share	$0.31		-$0.73
Diluted Earnings Per Share	$0.31	-$1.64	-$0.73
COMMON SHARES
Basic Shares Outstanding	449.2M shares		454.8M shares
Diluted Shares Outstanding	453.5M shares		456.2M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$895.7M	$1.469B	$1.469B
YoY Change	0.75%	18.99%	18.99%
Cash & Equivalents	$895.7M	$1.469B	$1.469B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$708.3M	$701.5M	$701.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$895.7M	$1.469B	$1.469B
YoY Change	-47.15%	18.99%	18.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$583.6M	$599.5M	$918.8M
YoY Change	1.92%	6.84%	-0.34%
Goodwill	$8.621B	$8.692B
YoY Change	0.21%	1.56%
Intangibles	$5.832B	$5.848B
YoY Change	-18.21%	-18.11%
Long-Term Investments	$10.08B	$9.935B	$9.935B
YoY Change	1432.37%	2.09%	2.09%
Other Assets
YoY Change
Total Long-Term Assets	$27.18B	$27.46B	$27.46B
YoY Change	-3.06%	-3.71%	-3.71%
TOTAL ASSETS
Total Short-Term Assets	$895.7M	$1.469B	$1.469B
Total Long-Term Assets	$27.18B	$27.46B	$27.46B
Total Assets	$28.08B	$28.93B	$28.93B
YoY Change	-5.57%	-2.77%	-2.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.321B	$1.294B	$860.7M
YoY Change	-9.86%	-1.55%	3.13%
Accrued Expenses	$452.5M	$900.4M	$1.334B
YoY Change	4.09%	4.6%	-0.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.774B	$393.9M	$393.9M
YoY Change	-30.42%	-41.09%	-41.09%
LONG-TERM LIABILITIES
Long-Term Debt	$8.628B	$8.611B	$8.611B
YoY Change	4.42%	6.6%	6.6%
Other Long-Term Liabilities	$3.597B	$4.013B	$4.013B
YoY Change	754.68%	-3.73%	-3.73%
Total Long-Term Liabilities	$12.22B	$12.62B	$12.62B
YoY Change	40.78%	3.09%	3.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.774B	$393.9M	$393.9M
Total Long-Term Liabilities	$12.22B	$12.62B	$12.62B
Total Liabilities	$13.52B	$14.34B	$14.34B
YoY Change	4.63%	-1.42%	-1.42%
SHAREHOLDERS EQUITY
Retained Earnings	$6.878B	$6.827B
YoY Change	-9.23%	-9.2%
Common Stock	$7.428B	$7.565B
YoY Change	-1.3%	-1.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.864B	$3.003B
YoY Change	-0.82%	-1.26%
Treasury Stock Shares
Shareholders Equity	$14.55B	$14.60B	$14.60B
YoY Change
Total Liabilities & Shareholders Equity	$28.08B	$28.93B	$28.93B
YoY Change	-5.57%	-2.77%	-2.77%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$141.5M	-$742.3M	-$333.7M
YoY Change	-2.41%	-495.26%	-148.79%
Depreciation, Depletion And Amortization	$11.30M	$60.30M	$98.80M
YoY Change	-75.85%	210.82%	54.86%
Cash From Operating Activities	-$54.40M	$714.3M	$1.301B
YoY Change	-44.99%	56.47%	86.84%
INVESTING ACTIVITIES
Capital Expenditures	$21.00M	$40.30M	$164.3M
YoY Change	-44.88%	-44.87%	-14.83%
Acquisitions
YoY Change
Other Investing Activities	-$266.3M	-$221.3M	-$46.20M
YoY Change	-418.54%	-11.62%	-87.47%
Cash From Investing Activities	-$287.3M	-$261.6M	-$244.3M
YoY Change	-731.43%	100.31%	-33.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$148.3M	-110.3M	-$585.4M
YoY Change	-16.92%	-34.38%	-39.46%
NET CHANGE
Cash From Operating Activities	-$54.40M	714.3M	$1.301B
Cash From Investing Activities	-$287.3M	-261.6M	-$244.3M
Cash From Financing Activities	-$148.3M	-110.3M	-$585.4M
Net Change In Cash	-$490.0M	342.4M	$471.1M
YoY Change	111.3%	116.98%	-173.69%
FREE CASH FLOW
Cash From Operating Activities	-$54.40M	$714.3M	$1.301B
Capital Expenditures	$21.00M	$40.30M	$164.3M
Free Cash Flow	-$75.40M	$674.0M	$1.137B
YoY Change	-44.96%	75.8%	125.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	1825200000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1725100000	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	98600000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60900000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	236800000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	357900000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000914208
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://www.invesco.com/20231231#TotalTransactionAndIntegrationCharges
CY2022	us-gaap	Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://www.invesco.com/20231231#TotalTransactionAndIntegrationCharges
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-13908
CY2023	dei	Entity Registrant Name EntityRegistrantName	Invesco Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0557567
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1331 Spring Street,
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2500,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30309
CY2023	dei	City Area Code CityAreaCode	(404)
CY2023	dei	Local Phone Number LocalPhoneNumber	892-0896
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.20 par value
CY2023	dei	Trading Symbol TradingSymbol	IVZ
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6000000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	449204268	shares
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1469200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1234700000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	701500000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	801800000	usd
CY2023Q4	us-gaap	Investments Investments	919100000	usd
CY2022Q4	us-gaap	Investments Investments	996600000	usd
CY2023Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	462400000	usd
CY2022Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	199400000	usd
CY2023Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	250100000	usd
CY2022Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	203700000	usd
CY2023Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8765900000	usd
CY2022Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8531400000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	393900000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	668700000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	832600000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	860500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	599500000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	561100000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5848100000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7141200000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	8691500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8557700000	usd
CY2023Q4	us-gaap	Assets Assets	28933800000	usd
CY2022Q4	us-gaap	Assets Assets	29756800000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	900400000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	860800000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1294400000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1314800000	usd
CY2023Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	7121800000	usd
CY2022Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6590400000	usd
CY2023Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	492100000	usd
CY2022Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	329600000	usd
CY2023Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	393900000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	668700000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1489500000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1487600000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1325700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1662700000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13017800000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12914600000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	745700000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	998700000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	113200000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	113200000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7451600000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7554900000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3002600000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3040900000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6826700000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7518300000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-801800000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-942400000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14597600000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15213600000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	572700000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	629900000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15170300000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15843500000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28933800000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29756800000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5716400000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6048900000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6894500000	usd
CY2022	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	1886200000	usd
CY2021	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	2149300000	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1911300000	usd
CY2023	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	41600000	usd
CY2023	ivz	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	1298800000	usd
CY2022	ivz	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	63800000	usd
CY2021	ivz	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	62900000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6151200000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4731200000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5106300000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-434800000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1317700000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1788200000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	71300000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	106100000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	152300000	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	47800000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	24400000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	25200000	usd
CY2023	us-gaap	Interest Expense InterestExpense	70500000	usd
CY2022	us-gaap	Interest Expense InterestExpense	85200000	usd
CY2021	us-gaap	Interest Expense InterestExpense	94700000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	98000000.0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-139500000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120500000	usd
CY2023	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	50300000	usd
CY2022	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	24200000	usd
CY2021	ivz	Other Non Operating Income Expense Consolidated Investment Products OtherNonOperatingIncomeExpenseConsolidatedInvestmentProducts	509000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-237900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1247700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2500500000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-69700000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	322200000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531100000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-168200000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	925500000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-71300000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4800000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	339600000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-333700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	683900000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1393000000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.50
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.99
CY2023	us-gaap	Profit Loss ProfitLoss	-168200000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	925500000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	144900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-463100000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-73400000	usd
CY2023	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-4300000	usd
CY2022	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-37800000	usd
CY2021	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	36400000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27600000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	424600000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1932400000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-71300000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4800000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	339600000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	236800000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-193100000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	183000000.0	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1356000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-168200000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	925500000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	1969400000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	182800000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	195300000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	205300000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1248900000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	114600000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	106200000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	140100000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	97300000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-139500000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	120500000	usd
CY2023	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	-176300000	usd
CY2022	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	-126900000	usd
CY2021	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	390000000.0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	71300000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	106100000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	152300000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	69400000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	74200000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	48200000	usd
CY2023	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	50800000	usd
CY2022	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	359200000	usd
CY2021	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	421600000	usd
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-69400000	usd
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	27600000	usd
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-93800000	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-448700000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-912800000	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-5581200000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-621700000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1284300000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5875500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1300800000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	703200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1078100000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	164300000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	192900000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	108800000	usd
CY2023	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	3214400000	usd
CY2022	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	2717200000	usd
CY2021	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	5981800000	usd
CY2023	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	3111600000	usd
CY2022	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	2638400000	usd
CY2021	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	5281500000	usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	65200000	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	217800000	usd
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	191100000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	26800000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	97900000	usd
CY2021	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	129200000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	23300000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	32600000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	44900000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-46200000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	-8300000	usd
CY2022	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	-16600000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-244300000	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	236800000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	334800000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	307700000	usd
CY2023	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	201200000	usd
CY2022	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	709200000	usd
CY2021	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	628900000	usd
CY2023	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	255600000	usd
CY2022	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	284800000	usd
CY2021	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	395500000	usd
CY2023	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	703000000.0	usd
CY2022	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	30100000	usd
CY2021	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	3411900000	usd
CY2023	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	451800000	usd
CY2022	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	5100000	usd
CY2021	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	2497300000	usd
CY2023	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
CY2022	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	600000000.0	usd
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
CY2023	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
CY2022	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
CY2021	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	309400000	usd
CY2023	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	0	usd
CY2022	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	0	usd
CY2021	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	-104100000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	11800000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-585400000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-966900000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	117300000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	471100000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-639300000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	347500000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24000000.0	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-68600000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-32200000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1434100000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2147100000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1839300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1931600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1434100000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2147100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1469200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1234700000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896400000	usd
CY2023Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	462400000	usd
CY2022Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	199400000	usd
CY2021Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	250700000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1931600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1434100000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2147100000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	68200000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	67400000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	85700000	usd
CY2023	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	31000000.0	usd
CY2022	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	8700000	usd
CY2021	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	700000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	195100000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	301400000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	431700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15843500000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	998700000	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-132100000	usd
CY2023	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-36100000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	140600000	usd
CY2023	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	22000000.0	usd
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-216900000	usd
CY2023	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	59.00
CY2023	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	236800000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.7875
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	357900000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	114600000	usd
CY2023	ivz	Vested Shares VestedShares	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	7900000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	187500000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15170300000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	745700000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16168000000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	510800000	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	929500000	usd
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-4000000.0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-500900000	usd
CY2022	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	51100000	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	491900000	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	59.00
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	236800000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.73
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	334800000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	106200000	usd
CY2022	ivz	Vested Shares VestedShares	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	8100000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	244700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15843500000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	998700000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	usd
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	211800000	usd
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1931400000	usd
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	38000000.0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	usd
CY2021	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	76500000	usd
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	261000000.0	usd
CY2021	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	59.00
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	236800000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.67
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	308800000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140100000	usd
CY2021	ivz	Vested Shares VestedShares	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	7600000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	60900000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16168000000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	510800000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the Consolidated Financial Statements, management is required to make estimates and assumptions that affect reported revenues, expenses, assets, liabilities and disclosure of contingent liabilities. The primary estimates and assumptions relate to goodwill and intangible impairment, certain investments which are carried at fair value, post-employment benefit plan obligations, income taxes and contingent losses. Additionally, estimation is involved when determining investment and debt valuation for certain CIP; however, changes in the fair values of these amounts are largely offset by noncontrolling interests. Use of available information and application of judgment are inherent in the formation of estimates. Actual results in the future could differ from such estimates, and the differences may be material to the Consolidated Financial Statements.</span></div>
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2023	ivz	Share Based Payment Estimated Forfeitures Percentage ShareBasedPaymentEstimatedForfeituresPercentage	0.03
CY2023	ivz	Percentage Of Excess In Projected Benefit Obligation And Fair Value Assets To Be Amortized PercentageOfExcessInProjectedBenefitObligationAndFairValueAssetsToBeAmortized	0.100
CY2023	ivz	Percentage Of Excess In Projected Benefit Obligation And Fair Value Assets To Be Amortized PercentageOfExcessInProjectedBenefitObligationAndFairValueAssetsToBeAmortized	0.100
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	393900000	usd
CY2023	ivz	Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	Total return swap related to deferred compensation plans
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	4900000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1599000000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1300000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1754500000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	631800000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	621200000	usd
CY2023Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	0	usd
CY2022Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	25700000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	14900000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	24700000	usd
CY2023Q4	us-gaap	Investments Investments	919100000	usd
CY2022Q4	us-gaap	Investments Investments	996600000	usd
CY2023	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	61300000	usd
CY2022	ivz	Net Realizedand Unrealized Gainon Trading Securities NetRealizedandUnrealizedGainonTradingSecurities	-150400000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17200000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-44000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1544200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1690900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	935900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1121000000	usd
CY2023Q4	ivz	Property Plant And Equipment Accumulated Impairment PropertyPlantAndEquipmentAccumulatedImpairment	8800000	usd
CY2022Q4	ivz	Property Plant And Equipment Accumulated Impairment PropertyPlantAndEquipmentAccumulatedImpairment	8800000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	599500000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	561100000	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	132900000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	131500000	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	142400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1121000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1074500000	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	132900000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	131500000	usd
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	327100000	usd
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	61600000	usd
CY2023	ivz	Foreign Currency Increase Decrease Accumulated Depreciation ForeignCurrencyIncreaseDecreaseAccumulatedDepreciation	9100000	usd
CY2022	ivz	Foreign Currency Increase Decrease Accumulated Depreciation ForeignCurrencyIncreaseDecreaseAccumulatedDepreciation	-23400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	935900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1121000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7474000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1625900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5848100000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7463300000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	322100000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7141200000	usd
CY2022Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	19100000	usd
CY2023Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	19100000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49900000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	63800000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	44800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	37700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	35900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8557700000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	133800000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	8691500000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8882500000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-324800000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8557700000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	98300000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	87800000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	802100000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	773000000.0	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	900400000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	860800000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	567500000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	606500000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	433700000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	480200000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	31500000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	59600000	usd
CY2023Q4	ivz	Unsettled Funds Payable UnsettledFundsPayable	151200000	usd
CY2022Q4	ivz	Unsettled Funds Payable UnsettledFundsPayable	79400000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	110500000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	89100000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1294400000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1314800000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2023	ivz	Preferred Stock Lockup Period PreferredStockLockupPeriod	P5Y
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2023Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	116600000	shares
CY2022Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	111300000	shares
CY2021Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	104900000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	449500000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	454800000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	461200000	shares
CY2023	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	9600000	shares
CY2023	ivz	Forward Contract Indexed To Issuers Equity Cost ForwardContractIndexedToIssuersEquityCost	150000000	usd
CY2022	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	8900000	shares
CY2022	ivz	Forward Contract Indexed To Issuers Equity Cost ForwardContractIndexedToIssuersEquityCost	200000000	usd
CY2023	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	1900000	shares
CY2022	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	2400000	shares
CY2023	ivz	Fair Value Of Shares Withheld FairValueOfSharesWithheld	37500000	usd
CY2022	ivz	Fair Value Of Shares Withheld FairValueOfSharesWithheld	44700000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	382200000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	532200000	usd
CY2023Q4	ivz	Treasury Shares Held As Unvested Restricted Stock Awards TreasurySharesHeldAsUnvestedRestrictedStockAwards	8100000	shares
CY2022Q4	ivz	Treasury Shares Held As Unvested Restricted Stock Awards TreasurySharesHeldAsUnvestedRestrictedStockAwards	8200000	shares
CY2023	ivz	Common Shares Market Price Per Share CommonSharesMarketPricePerShare	17.84
CY2023	ivz	Treasury Stock Common Shares Aggregate Market Value TreasuryStockCommonSharesAggregateMarketValue	2200000000	usd
CY2022Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	119500000	shares
CY2021Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	115700000	shares
CY2020Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	121600000	shares
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	11500000	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	11300000	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2700000	shares
CY2023	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	6000000.0	shares
CY2022	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	7100000	shares
CY2021	ivz	Treasury Stock Common Shares Distributed TreasuryStockCommonSharesDistributed	8400000	shares
CY2023	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	300000	shares
CY2022	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	400000	shares
CY2021	ivz	Commonsharesdistributedtomeet Esp Pobligation CommonsharesdistributedtomeetESPPobligation	200000	shares
CY2023Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	124700000	shares
CY2022Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	119500000	shares
CY2021Q4	ivz	Treasury Stock Held Including Shares For Unvested Restricted Stock Awards TreasuryStockHeldIncludingSharesForUnvestedRestrictedStockAwards	115700000	shares
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	144900000	usd
CY2023	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-4300000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	140600000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	140600000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-463100000	usd
CY2022	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-37800000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-500900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-500900000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-73400000	usd
CY2021	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	36400000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000.0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	114600000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	106200000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	140100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17400000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	21700000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	30000000	usd
CY2023	ivz	Number Of Share Awards By Type NumberOfShareAwardsByType	2	award
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.03
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.53
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	16.68
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.11
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.84
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	101400000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	141800000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	187900000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.53
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.23
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.61
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	121400000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y5M8D
CY2023	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	44300000	usd
CY2022	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	41000000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	7100000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	34800000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	29700000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	13900000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	36800000	usd
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	41600000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	7100000	usd
CY2023	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	89100000	usd
CY2022	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	74500000	usd
CY2023Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	304800000	usd
CY2022Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	260500000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y11M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y3M7D
CY2023Q4	ivz	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	1	lease_renewal_option
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	319300000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	433700000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	75400000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	82900000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	81400000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	25900000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	19000000.0	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	25500000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	2300000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1600000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	1900000	usd
CY2023	us-gaap	Lease Cost LeaseCost	99000000.0	usd
CY2022	us-gaap	Lease Cost LeaseCost	100300000	usd
CY2021	us-gaap	Lease Cost LeaseCost	105000000.0	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	80800000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	70700000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22700000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	214800000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0414
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0378
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	64600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	66000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	62100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	55200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	45100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	237000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	530000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	96300000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	433700000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	164000000.0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	214100000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	287500000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42700000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	50200000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	68700000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	32800000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9600000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	95200000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	239500000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	273900000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	451400000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-235300000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	35200000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	72700000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-44100000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1100000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22200000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-29800000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	14200000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-15200000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-309200000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48300000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	79700000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-69700000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	322200000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531100000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	95600000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.032
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.111
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.063
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.029
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	-0.074
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.017
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.009
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.029
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2023	ivz	Effective Income Tax Rate Reconciliation Nontaxable Gains Percent EffectiveIncomeTaxRateReconciliationNontaxableGainsPercent	0.039
CY2022	ivz	Effective Income Tax Rate Reconciliation Nontaxable Gains Percent EffectiveIncomeTaxRateReconciliationNontaxableGainsPercent	0
CY2021	ivz	Effective Income Tax Rate Reconciliation Nontaxable Gains Percent EffectiveIncomeTaxRateReconciliationNontaxableGainsPercent	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.046
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.035
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.293
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.212
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-469200000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1212000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2089500000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	231300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	35700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	411000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-237900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1247700000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2500500000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	97800000	usd
CY2023Q4	ivz	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	66700000	usd
CY2022Q4	ivz	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	67200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	154300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	124400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	15700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	34400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	37100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	371600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	342600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	98900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	93500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	272700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	249100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1519100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1796100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	55900000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	58400000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	21800000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	27300000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1596800000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1881800000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1324100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1632700000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1325700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1662700000	usd
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1068800000	usd
CY2022Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1034000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100200000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	86600000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61900000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	9600000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	16200000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	15900000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1300000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	3100000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	14200000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7700000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1200000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3500000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2100000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	10300000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2400000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	91300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100200000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	86600000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	72600000	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	17000000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	15100000	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	14800000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-333700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	683900000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1393000000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	454800000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	457500000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	462800000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1400000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000.0	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2600000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	456200000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	459500000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	465400000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.50
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.99
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5716400000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	599500000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6048900000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	561100000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6894500000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	518100000	usd
CY2023	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	623300000	usd
CY2022	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	336100000	usd
CY2023Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	462400000	usd
CY2022Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	199400000	usd
CY2023Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	250100000	usd
CY2022Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	203700000	usd
CY2023Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8765900000	usd
CY2022Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8531400000	usd
CY2023Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	7121800000	usd
CY2022Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6590400000	usd
CY2023Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	492100000	usd
CY2022Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	329600000	usd
CY2023Q4	ivz	Retainedearningsadjustmentfor Cip RetainedearningsadjustmentforCIP	100000	usd
CY2022Q4	ivz	Retainedearningsadjustmentfor Cip RetainedearningsadjustmentforCIP	100000	usd
CY2023Q4	ivz	Redeemable Noncontrolling Interest Consolidated Investment Products RedeemableNoncontrollingInterestConsolidatedInvestmentProducts	745700000	usd
CY2022Q4	ivz	Redeemable Noncontrolling Interest Consolidated Investment Products RedeemableNoncontrollingInterestConsolidatedInvestmentProducts	998700000	usd
CY2023Q4	ivz	Nonredeemable Noncontrolling Interest Consolidated Investment Products NonredeemableNoncontrollingInterestConsolidatedInvestmentProducts	572700000	usd
CY2022Q4	ivz	Nonredeemable Noncontrolling Interest Consolidated Investment Products NonredeemableNoncontrollingInterestConsolidatedInvestmentProducts	629300000	usd
CY2023Q4	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	546200000	usd
CY2022Q4	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	386600000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	463600000	usd
CY2023Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8765900000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	552000000.0	usd
CY2022Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8531400000	usd
CY2023	ivz	Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High CollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.1338
CY2023	ivz	Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High CollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.1338
CY2023	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread Low NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadLow	0.0040
CY2023	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.0868
CY2023Q4	ivz	Collateral Assets Default Percentage CollateralAssetsDefaultPercentage	0.0007
CY2022Q4	ivz	Collateral Assets Default Percentage CollateralAssetsDefaultPercentage	0.0049
CY2023	ivz	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List Not Disclosed Flag FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleListNotDisclosedFlag	Gains and losses included in the Consolidated Statements of Income
CY2022	ivz	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List Not Disclosed Flag FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleListNotDisclosedFlag	Gains and losses included in the Consolidated Statements of Income
CY2023Q4	ivz	Variable Interest Entity Reporting Entity Involvement Unfunded Capital Commitments Amount VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount	142500000	usd
CY2022Q4	ivz	Variable Interest Entity Reporting Entity Involvement Unfunded Capital Commitments Amount VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount	100500000	usd
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000914208-24-000219-index-headers.html	Edgar Link	pending
0000914208-24-000219-index.html	Edgar Link	pending
0000914208-24-000219.txt	Edgar Link	pending
0000914208-24-000219-xbrl.zip	Edgar Link	pending
ex231pwcconsentq42023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_0b.jpg	Edgar Link	pending
ivz-20231231.htm	Edgar Link	pending
ivz-20231231.xsd	Edgar Link	pending
ivz-20231231_g1.jpg	Edgar Link	pending
ivz-20231231_g2.jpg	Edgar Link	pending
ivz-20231231_g3.jpg	Edgar Link	pending
ivz-20231231_g4.jpg	Edgar Link	pending
ivz-20231231_g5.jpg	Edgar Link	pending
ivz-20231231_g6.jpg	Edgar Link	pending
ivz10k2023ex1027.htm	Edgar Link	pending
ivz10k2023ex1030.htm	Edgar Link	pending
ivz10k2023ex210.htm	Edgar Link	pending
ivz10k2023ex220.htm	Edgar Link	pending
ivz10k2023ex311.htm	Edgar Link	pending
ivz10k2023ex312.htm	Edgar Link	pending
ivz10k2023ex321.htm	Edgar Link	pending
ivz10k2023ex322.htm	Edgar Link	pending
ivz10k2023ex97.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
ivz-20231231_cal.xml	Edgar Link	unprocessable
ivz-20231231_lab.xml	Edgar Link	unprocessable
ivz-20231231_pre.xml	Edgar Link	unprocessable
ivz-20231231_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ivz-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVZ
Invesco Ltd Stock $ivz

2024 Q1 Form 10-K Financial Statement

#000091420824000219 Filed on February 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ Invesco Ltd Stock $ivz

2024 Q1 Form 10-K Financial Statement

#000091420824000219 Filed on February 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ
Invesco Ltd Stock $ivz